Clinical trial

Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety

NCT00241397 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed

Key facts

NCT number NCT00241397
Title Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety
Official title An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.
Lead sponsor Wyeth is now a wholly owned subsidiary of Pfizer, Industry
Status Completed
Study type Observational
Conditions Pain, Depression, Anxiety Disorder
Enrollment 2,560
Start date Nov 1, 2005
First posted Oct 18, 2005
Last update posted Mar 15, 2007
Countries Belgium

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies